Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

407 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sensor-augmented pump therapy in type 1 diabetes.
Weinzimer SA, Tamborlane WV. Weinzimer SA, et al. Among authors: tamborlane wv. Curr Opin Endocrinol Diabetes Obes. 2008 Apr;15(2):118-22. doi: 10.1097/MED.0b013e3282f7960b. Curr Opin Endocrinol Diabetes Obes. 2008. PMID: 18316945 Review.
Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy.
Swan KL, Dziura JD, Steil GM, Voskanyan GR, Sikes KA, Steffen AT, Martin ML, Tamborlane WV, Weinzimer SA. Swan KL, et al. Among authors: tamborlane wv. Diabetes Care. 2009 Feb;32(2):240-4. doi: 10.2337/dc08-0595. Epub 2008 Nov 18. Diabetes Care. 2009. PMID: 19017777 Free PMC article.
Comparison of glycemic variability associated with insulin glargine and intermediate-acting insulin when used as the basal component of multiple daily injections for adolescents with type 1 diabetes.
White NH, Chase HP, Arslanian S, Tamborlane WV; 4030 Study Group. White NH, et al. Among authors: tamborlane wv. Diabetes Care. 2009 Mar;32(3):387-93. doi: 10.2337/dc08-0800. Epub 2008 Dec 23. Diabetes Care. 2009. PMID: 19106380 Free PMC article. Clinical Trial.
The effect of continuous glucose monitoring in well-controlled type 1 diabetes.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group; Beck RW, Hirsch IB, Laffel L, Tamborlane WV, Bode BW, Buckingham B, Chase P, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Huang ES, Kollman C, Kowalski AJ, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer SA, Wilson DM, Wolpert H, Wysocki T, Xing D. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, et al. Among authors: tamborlane wv. Diabetes Care. 2009 Aug;32(8):1378-83. doi: 10.2337/dc09-0108. Epub 2009 May 8. Diabetes Care. 2009. PMID: 19429875 Free PMC article. Clinical Trial.
Sustained benefit of continuous glucose monitoring on A1C, glucose profiles, and hypoglycemia in adults with type 1 diabetes.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group; Bode B, Beck RW, Xing D, Gilliam L, Hirsch I, Kollman C, Laffel L, Ruedy KJ, Tamborlane WV, Weinzimer S, Wolpert H. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, et al. Among authors: tamborlane wv. Diabetes Care. 2009 Nov;32(11):2047-9. doi: 10.2337/dc09-0846. Epub 2009 Aug 12. Diabetes Care. 2009. PMID: 19675193 Free PMC article. Clinical Trial.
407 results